Technology News

Amazon’s Eero unveils the weatherproof Outdoor 7 to extend Wi-Fi coverage across your property.

New iPads are here. We break down the current lineup to help you figure out which one of Apple’s tablets is best for you.

Maximize your travel enjoyment while minimizing your stuff by flying with only one small bag.

When Canadian developer Peter Todd found out that a new HBO documentary, Money Electric: The Bitcoin Mystery, was set to identify him as Satoshi Nakamoto, the creator of bitcoin, he was mostly just pissed. “This was clearly going to be a circus,” Todd told WIRED in an email.

The identity of the person—or people—who created bitcoin has been the subject of speculation since December 2010, when they disappeared from public view. The mystery has proved all the more irresistible for the trove of bitcoin Satoshi is widely believed to have controlled, suspected to be worth many billions of dollars today. When the documentary was released on October 8, Todd joined a long line of alleged Satoshis.

Documentary maker Cullen Hoback, who in a previous film claimed to have identified the individual behind QAnon, laid out his theory to Todd on camera. The confrontation would become the climactic scene of the documentary. But Todd nonetheless claims he didn’t see it coming; he alleges he was left with the impression the film was about the history of bitcoin, not the identity of its creator.

Read full article

Comments

Nintendo’s alarm clock does less than we want it to for more than we want to pay. You might want to buy one anyway.

The niche coffee maker brews a great cup of coffee. But at this price, parts of the machine should be better quality.

WIRED’s AI Unlocked newsletter about using chatbots and other generative AI tools is back for a second season. We’ve incorporated reader feedback and answered your burning questions.

T-Mobile promised users who bought certain mobile plans that it would never raise their prices for as long as they lived—but then raised their prices this year. So it's no surprise that 2,000 T-Mobile customers complained to the government about a price hike on plans that were advertised as having a lifetime price lock.

"I am still alive and T-Mobile is increasing the price for service by $5 per line. How is this a lifetime price lock?" one customer in Connecticut asked the Federal Communications Commission in a complaint that we obtained through a public records request.

"I am not dead yet," a customer in New York wrote bluntly, saying they had bought a plan with a "guarantee for life."

Read full article

Comments

These earplugs let you fine-tune your noise reduction—within reason.

The agency also cautioned that it’s unable to get a grasp on the full scale of the threat, due to extremists increasingly using encrypted chat tools.

Meta’s most affordable VR headset is cheap, light, and easy to use. Just don’t expect to wear it too long, as the battery life isn't great.

Mobile carriers argue that locking devices helps them lower costs. Consumer protection groups see it a little differently.

Mobile carriers argue that locking devices helps them lower costs. Consumer protection groups see it a little differently.

Around the world, seeds of regenerative cities have already been planted. As they grow, they will shape the metropolises of tomorrow.

United Launch Alliance has started assembling its next Vulcan rocket—the first destined to launch a US military payload—as the Space Force prepares to certify it to loft the Pentagon's most precious national security satellites.

Space Force officials expect to approve ULA's Vulcan rocket for military missions without requiring another test flight, despite an unusual problem on the rocket's second demonstration flight earlier this month.

ULA has launched two Vulcan test flights. Military officials watched closely, gathering data to formally certify the rocket is reliable enough to launch national security missions. The first test flight in January, designated Cert-1, was nearly flawless. The Cert-2 launch October 4 overcame an anomaly on one of Vulcan's strap-on solid rocket boosters, which lost its exhaust nozzle but kept firing with degraded thrust.

Read full article

Comments

Colossal, the company founded to try to restore the mammoth to the Arctic tundra, has also decided to tackle a number of other species that have gone extinct relatively recently: the dodo and the thylacine. Because of significant differences in biology, not the least of which is the generation time of Proboscideans, these other efforts may reach many critical milestones well in advance of the work on mammoths.

Late last week, Colossal released a progress report on the work involved in resurrecting the thylacine, also known as the Tasmanian tiger, which went extinct when the last known survivor died in a zoo in 1936. Marsupial biology has some features that may make de-extinction somewhat easier, but we have far less sophisticated ways of manipulating it compared to the technology we've developed for working with the stem cells and reproduction of placental mammals. But, based on these new announcements, the technology available for working with marsupials is expanding rapidly.

Cane toad resistance

Colossal has branched out from its original de-extinction mission to include efforts to keep species from ever needing its services. In the case of marsupial predators, the de-extinction effort is incorporating work that will benefit existing marsupial predators: generating resistance to the toxins found on the cane toad, an invasive species that has spread widely across Australia.

Read full article

Comments

Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an outlandish scheme to sell do-it-yourself kits to make illicit knockoff versions of weight-loss and diabetes drugs, Zepbound and Mounjaro.

For the alleged scheme, vendor Pivotal Peptides has customers buy a set of ingredients they have to mix together to create their own injectable versions of the drugs. Customers don't need a prescription or even a medical consultation to order the kit, even though the brand-name drugs are prescription-only. That may not be surprising, though, since the dubious white powder customers receive is stated to be "a research chemical for lab research and veterinary purposes only." Once purchased, the kit's instructions recommend users disinfect their home work surface before beginning and stress the importance of using the sterile water included in the kit to dissolve the powder to the desired concentration. The instructions then explain how to inject oneself with the homemade mixture using a 30-gauge syringe.

That's all according to a lawsuit filed Monday by pharmaceutical giant Eli Lilly, maker of tirzepatide-based Zepbound and Mounjaro, which are sold as ready-to-use medicines in single-dose pens or vials. The lawsuit against Pivotal Peptides is one of three that Lilly filed this week, all accusing questionable drugmakers of unlawfully selling knockoff versions of its tirzepatide drugs that have not been tested or approved. But the one against Pivotal Peptides stands out for the scheme the owners allegedly used to sell their knockoff version.

Read full article

Comments

Subscription fees for video streaming services have been on a steady incline. But despite subscribers paying more, surveys suggest they're becoming less satisfied with what's available to watch.

At the start of 2024, the industry began declaring the end of Peak TV, a term coined by FX Networks Chairman John Landgraf that refers to an era of rampant content spending that gave us shows like The Wire, Breaking Bad, and Game of Thrones. For streaming services, the Peak TV era meant trying to lure subscribers with original content that was often buoyed by critical acclaim and/or top-tier actors, writers, and/or directors. However, as streaming services struggle to reach or maintain profitability, 2024 saw a drop in the number of new scripted shows for the first time in at least 10 years, FX Research found.

Meanwhile, overall satisfaction with the quality of content available on streaming services seems to have declined for the past couple of years. Most surveys suggest a generally small decline in perceived quality, but that’s still perturbing considering how frequently streaming services increase subscription fees. There was a time when a streaming subscription represented an exclusive ticket to viewing some of the best new TV shows and movies. But we’ve reached a point where the most streamed TV show last year was Suits—an original from the USA Network cable channel that ended in 2019.

Read full article

Comments

A stunning image of differentiated mouse brain tumor cells has won the 2024 Nikon Small World photomicrography contest, yielding valuable insight into how degenerate diseases like Alzheimer's and ALS can arise from disruption in the cytoskeleton of brain cells. The image was taken by Bruno Cisterna, with assistance from Eric Vitriol, both with Augusta University in Georgia.

"One of the main problems with neurodegenerative diseases is that we don't fully understand what causes them,” Cisterna said in a statement. “To develop effective treatments, we need to figure out the basics first. Our research is crucial for uncovering this knowledge and ultimately finding a cure. Differentiated cells could be used to study how mutations or toxic proteins that cause Alzheimer's or ALS alter neuronal morphology, as well as to screen potential drugs or gene therapies aimed at protecting neurons or restoring their function.”

It's the 50th anniversary of Nikon's annual contest, which was founded back in 1974 "to showcase the beauty and complexity of things seen through the light microscope." Photomicrography involves attaching a camera to a microscope (either an optical microscope or an electron microscope) so that the user can take photographs of objects at very high resolutions. British physiologist Richard Hill Norris was one of the first to use it for his studies of blood cells in 1850, and the method has increasingly been highlighted as art since the 1970s. There have been many groundbreaking technological advances in the ensuing decades, particularly with the advent of digital imaging methods.

Read full article

Comments

AI software company Anthropic has announced a new tool that can take control of the user's mouse cursor and perform basic tasks on their computer.

Announced alongside other improvements to Anthropic's Claude and Haiku models, the tool is straightforwardly called "Computer Use." It's available exclusively with the company's mid-range 3.5 Sonnet model right now, via the API. Users can give multi-step instructions (Anthropic claims it can go for tens or even hundreds of steps) to accomplish tasks on the user's computer by "looking at a screen, moving a cursor, clicking buttons, and typing text."

Here's how Anthropic says it works:

Read full article

Comments